A citation-based method for searching scientific literature

Aline Talhouk, Lien N Hoang, Melissa K McConechy, Quentin Nakonechny, Joyce Leo, Angela Cheng, Samuel Leung, Winnie Yang, Amy Lum, Martin Köbel, Cheng-Han Lee, Robert A Soslow, David G Huntsman, C Blake Gilks, Jessica N McAlpine. Gynecol Oncol 2016
Times Cited: 97







List of co-cited articles
618 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Integrated genomic characterization of endometrial carcinoma.
Cyriac Kandoth, Nikolaus Schultz, Andrew D Cherniack, Rehan Akbani, Yuexin Liu, Hui Shen, A Gordon Robertson, Itai Pashtan, Ronglai Shen, Christopher C Benz,[...]. Nature 2013
78

Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
Aline Talhouk, Melissa K McConechy, Samuel Leung, Winnie Yang, Amy Lum, Janine Senz, Niki Boyd, Judith Pike, Michael Anglesio, Janice S Kwon,[...]. Cancer 2017
291
67

A clinically applicable molecular-based classification for endometrial cancers.
A Talhouk, M K McConechy, S Leung, H H Li-Chang, J S Kwon, N Melnyk, W Yang, J Senz, N Boyd, A N Karnezis,[...]. Br J Cancer 2015
336
60

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.
Ellen Stelloo, Remi A Nout, Elisabeth M Osse, Ina J Jürgenliemk-Schulz, Jan J Jobsen, Ludy C Lutgens, Elzbieta M van der Steen-Banasik, Hans W Nijman, Hein Putter, Tjalling Bosse,[...]. Clin Cancer Res 2016
304
59

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series.
S Kommoss, M K McConechy, F Kommoss, S Leung, A Bunz, J Magrill, H Britton, F Kommoss, F Grevenkamp, A Karnezis,[...]. Ann Oncol 2018
201
49

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.
Ellen Stelloo, Tjalling Bosse, Remi A Nout, Helen J MacKay, David N Church, Hans W Nijman, Alexandra Leary, Richard J Edmondson, Melanie E Powell, Emma J Crosbie,[...]. Mod Pathol 2015
229
42

Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma.
C Blake Gilks, Esther Oliva, Robert A Soslow. Am J Surg Pathol 2013
199
41

High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma.
Ellen Stelloo, Remi A Nout, Lisanne C L M Naves, Natalja T Ter Haar, Carien L Creutzberg, Vincent T H B M Smit, Tjalling Bosse. Gynecol Oncol 2014
50
58

Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis.
Melissa K McConechy, Aline Talhouk, Samuel Leung, Derek Chiu, Winnie Yang, Janine Senz, Linda J Reha-Krantz, Cheng-Han Lee, David G Huntsman, C Blake Gilks,[...]. Clin Cancer Res 2016
97
26

Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups.
Tjalling Bosse, Remi A Nout, Jessica N McAlpine, Melissa K McConechy, Heidi Britton, Yaser R Hussein, Carlene Gonzalez, Raji Ganesan, Jane C Steele, Beth T Harrison,[...]. Am J Surg Pathol 2018
112
25

Prognostic significance of POLE proofreading mutations in endometrial cancer.
David N Church, Ellen Stelloo, Remi A Nout, Nadejda Valtcheva, Jeroen Depreeuw, Natalja ter Haar, Aurelia Noske, Frederic Amant, Ian P M Tomlinson, Peter J Wild,[...]. J Natl Cancer Inst 2014
176
24

Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations.
Yaser R Hussein, Britta Weigelt, Douglas A Levine, J Kenneth Schoolmeester, Linda N Dao, Bonnie L Balzer, Georgia Liles, Beth Karlan, Martin Köbel, Cheng-Han Lee,[...]. Mod Pathol 2015
118
23

Reproducibility of histological cell type in high-grade endometrial carcinoma.
Guangming Han, Davinder Sidhu, Máire A Duggan, Jocelyne Arseneau, Matthew Cesari, Philip B Clement, Carol A Ewanowich, Steve E Kalloger, Martin Köbel. Mod Pathol 2013
122
22


ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.
N Colombo, C Creutzberg, F Amant, T Bosse, A González-Martín, J Ledermann, C Marth, R Nout, D Querleu, M R Mirza,[...]. Ann Oncol 2016
503
21

Classification of endometrial carcinoma: more than two types.
Rajmohan Murali, Robert A Soslow, Britta Weigelt. Lancet Oncol 2014
322
18

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.
C L Creutzberg, W L van Putten, P C Koper, M L Lybeert, J J Jobsen, C C Wárlám-Rodenhuis, K A De Winter, L C Lutgens, A C van den Bergh, E van de Steen-Banasik,[...]. Lancet 2000
18

Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup.
Lien N Hoang, Mary A Kinloch, Joyce M Leo, Katherine Grondin, Cheng-Han Lee, Carol Ewanowich, Martin Köbel, Angela Cheng, Aline Talhouk, Melissa McConechy,[...]. Am J Surg Pathol 2017
51
35

The genetic landscape of endometrial clear cell carcinomas.
Deborah F DeLair, Kathleen A Burke, Pier Selenica, Raymond S Lim, Sasinya N Scott, Sumit Middha, Abhinita S Mohanty, Donavan T Cheng, Michael F Berger, Robert A Soslow,[...]. J Pathol 2017
104
18

Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas.
Alicia León-Castillo, Ester Gilvazquez, Remi Nout, Vincent Thbm Smit, Jessica N McAlpine, Melissa McConechy, Stefan Kommoss, Sara Y Brucker, Joseph W Carlson, Elisabeth Epstein,[...]. J Pathol 2020
87
20


Histopathological features of endometrial carcinomas associated with POLE mutations: implications for decisions about adjuvant therapy.
Salwa Bakhsh, Mary Kinloch, Lien N Hoang, Robert A Soslow, Martin Köbel, Cheng-Han Lee, Jessica N McAlpine, Melissa K McConechy, C Blake Gilks. Histopathology 2016
42
40

Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
Lien N Hoang, Melissa K McConechy, Martin Köbel, Guangming Han, Marjan Rouzbahman, Ben Davidson, Julie Irving, Rola H Ali, Sam Leung, Jessica N McAlpine,[...]. Am J Surg Pathol 2013
82
20

Interpretation of somatic POLE mutations in endometrial carcinoma.
Alicia León-Castillo, Heidi Britton, Melissa K McConechy, Jessica N McAlpine, Remi Nout, Stefan Kommoss, Sara Y Brucker, Joseph W Carlson, Elisabeth Epstein, Tilman T Rau,[...]. J Pathol 2020
81
20

p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies.
Naveena Singh, Anna M Piskorz, Tjalling Bosse, Mercedes Jimenez-Linan, Brian Rous, James D Brenton, C Blake Gilks, Martin Köbel. J Pathol 2020
63
26

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
N Colombo, E Preti, F Landoni, S Carinelli, A Colombo, C Marini, C Sessa. Ann Oncol 2013
341
16

POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium.
Bo Meng, Lien N Hoang, John B McIntyre, Máire A Duggan, Gregg S Nelson, Cheng-Han Lee, Martin Köbel. Gynecol Oncol 2014
120
16

CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.
Katherine C Kurnit, Grace N Kim, Bryan M Fellman, Diana L Urbauer, Gordon B Mills, Wei Zhang, Russell R Broaddus. Mod Pathol 2017
123
16

Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1.
Brooke E Howitt, Sachet A Shukla, Lynette M Sholl, Lauren L Ritterhouse, Jaclyn C Watkins, Scott Rodig, Elizabeth Stover, Kyle C Strickland, Alan D D'Andrea, Catherine J Wu,[...]. JAMA Oncol 2015
363
15

Just how accurate are the major risk stratification systems for early-stage endometrial cancer?
S Bendifallah, G Canlorbe, P Collinet, E Arsène, F Huguet, C Coutant, D Hudry, O Graesslin, E Raimond, C Touboul,[...]. Br J Cancer 2015
80
18

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
14

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.
Henry M Keys, James A Roberts, Virginia L Brunetto, Richard J Zaino, Nick M Spirtos, Jeffrey D Bloss, Andrew Pearlman, Mitchell A Maiman, Jeffrey G Bell. Gynecol Oncol 2004
14

L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.
Alain G Zeimet, Daniel Reimer, Monica Huszar, Boris Winterhoff, Ulla Puistola, Samira Abdel Azim, Elisabeth Müller-Holzner, Alon Ben-Arie, Léon C van Kempen, Edgar Petru,[...]. J Natl Cancer Inst 2013
138
14

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy.
Alicia León-Castillo, Stephanie M de Boer, Melanie E Powell, Linda R Mileshkin, Helen J Mackay, Alexandra Leary, Hans W Nijman, Naveena Singh, Pamela M Pollock, Paul Bessette,[...]. J Clin Oncol 2020
126
13

DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer.
David N Church, Sarah E W Briggs, Claire Palles, Enric Domingo, Stephen J Kearsey, Jonathon M Grimes, Maggie Gorman, Lynn Martin, Kimberley M Howarth, Shirley V Hodgson,[...]. Hum Mol Genet 2013
220
12

L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results.
T Bosse, R A Nout, E Stelloo, E Dreef, H W Nijman, I M Jürgenliemk-Schulz, J J Jobsen, C L Creutzberg, V T H B M Smit. Eur J Cancer 2014
93
12

Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma.
Martin Köbel, Anna M Piskorz, Sandra Lee, Shuhong Lui, Cecile LePage, Francesco Marass, Nitzan Rosenfeld, Anne-Marie Mes Masson, James D Brenton. J Pathol Clin Res 2016
184
12

Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer.
Janice M Mehnert, Anshuman Panda, Hua Zhong, Kim Hirshfield, Sherri Damare, Katherine Lane, Levi Sokol, Mark N Stein, Lorna Rodriguez-Rodriquez, Howard L Kaufman,[...]. J Clin Invest 2016
238
11


Regression of Chemotherapy-Resistant Polymerase ε (POLE) Ultra-Mutated and MSH6 Hyper-Mutated Endometrial Tumors with Nivolumab.
Alessandro D Santin, Stefania Bellone, Natalia Buza, Jungmin Choi, Peter E Schwartz, Joseph Schlessinger, Richard P Lifton. Clin Cancer Res 2016
102
10


ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.
Nicoletta Colombo, Carien Creutzberg, Frederic Amant, Tjalling Bosse, Antonio González-Martín, Jonathan Ledermann, Christian Marth, Remi Nout, Denis Querleu, Mansoor Raza Mirza,[...]. Int J Gynecol Cancer 2016
314
10

TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers.
Anne M Schultheis, Luciano G Martelotto, Maria R De Filippo, Salvatore Piscuglio, Charlotte K Y Ng, Yaser R Hussein, Jorge S Reis-Filho, Robert A Soslow, Britta Weigelt. Int J Gynecol Pathol 2016
48
20

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber,[...]. Science 2017
10


Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.
Amanda N Fader, Dana M Roque, Eric Siegel, Natalia Buza, Pei Hui, Osama Abdelghany, Setsuko K Chambers, Angeles Alvarez Secord, Laura Havrilesky, David M O'Malley,[...]. J Clin Oncol 2018
171
10

Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial.
B G Wortman, T Bosse, R A Nout, L C H W Lutgens, E M van der Steen-Banasik, H Westerveld, H van den Berg, A Slot, K A J De Winter, K W Verhoeven-Adema,[...]. Gynecol Oncol 2018
87
11


Polymerase ɛ (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing.
Caroline C Billingsley, David E Cohn, David G Mutch, Julie A Stephens, Adrian A Suarez, Paul J Goodfellow. Cancer 2015
106
9

POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer.
Inge C van Gool, Florine A Eggink, Luke Freeman-Mills, Ellen Stelloo, Emanuele Marchi, Marco de Bruyn, Claire Palles, Remi A Nout, Cor D de Kroon, Elisabeth M Osse,[...]. Clin Cancer Res 2015
178
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.